Showing results (281-290 of 319) with videos related to

Sort By:
Pageof 32
Journal of the American College of Cardiology|February 7, 2026
Pulsed Field Ablation vs Standard Radiofrequency Ablation for Typical Atrial Flutter: ADVANTAGE AF Trial SubstudyEdward P Gerstenfeld, Boris Schmidt, Andrea Natale, et al.
American Heart Journal|August 28, 2022
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationalePablo B Nery, George A Wells, Atul Verma, et al.
Heart Rhythm|December 17, 2008
Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategiesClaude S Elayi, Atul Verma, Luigi Di Biase, et al.
The New England Journal of Medicine|November 7, 2022
Progression of Atrial Fibrillation after Cryoablation or Drug TherapyJason G Andrade, Marc W Deyell, Laurent Macle, et al.
Heart Rhythm|September 1, 2009
Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter studyMandeep Bhargava, Luigi Di Biase, Prasant Mohanty, et al.
Circulation|May 26, 2010
Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory CommitteeRatika Parkash, Eugene Crystal, Jamil Bashir, et al.
Circulation|August 6, 2017
Subclinical Atrial Fibrillation in Older PatientsJeff S Healey, Marco Alings, Andrew Ha, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 10, 2018
Prevention of venous thrombosis after electrophysiology procedures: a survey of national practiceBarry Burstein, Rodrigo S Barbosa, Michelle Samuel, et al.
Heart Rhythm|May 3, 2008
Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory CommitteeAndrew D Krahn, Jean Champagne, Jeffrey S Healey, et al.
Nature Medicine|February 14, 2025
Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trialIsabel Deisenhofer, Jean-Paul Albenque, Sonia Busch, et al.
Pageof 32